Thomas Cerny
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 59
- Lung Cancer Research Studies 13
- Cancer Treatment and Pharmacology 9
-
- Lymphoma Diagnosis and Treatment 26
- Co-authors
- Adrian Kupfer (12 shared papers)N. Thatcher (13 shared papers)Ulrich Güller (16 shared papers)Daniel C. Betticher (22 shared papers)Christine Aeschlimann (4 shared papers)Florian Strasser (9 shared papers)René Warschkow (14 shared papers)Bruno Martin Schmied (12 shared papers)
- Journals
- Annals of Oncology (28 papers)British Journal of Cancer (15 papers)Journal of Clinical Oncology (11 papers)Cancer Chemotherapy and Pharmacology (8 papers)Lung Cancer (6 papers)
- Partner nations
- SwitzerlandUnited KingdomGermany
In The Last Decade
Thomas Cerny
209 papers receiving 8.7k citations
Thomas Cerny's Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 2k
- Pathology and Forensic Medicine 1.1k
- Pulmonary and Respiratory Medicine 2k
- Otorhinolaryngology 204
- Genetics 295
Countries citing papers authored by Thomas Cerny
This map shows the geographic impact of Thomas Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cerny more than expected).
Fields of papers citing papers by Thomas Cerny
This network shows the impact of papers produced by Thomas Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cerny. The network helps show where Thomas Cerny may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cerny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multiple primary tumours: challenges and approaches, a review Hit paper breakdown → | 2017 | 397 |
| 2 | 2003 | 356 | |
| 3 | 2006 | 337 | |
| 4 | 2005 | 304 | |
| 5 | 2008 | 235 | |
| 6 | 1994 | 230 | |
| 7 | 2002 | 228 | |
| 8 | 2010 | 200 | |
| 9 | 1996 | 199 | |
| 10 | 1987 | 175 | |
| 11 | 2006 | 173 | |
| 12 | 2016 | 169 | |
| 13 | 2011 | 162 | |
| 14 | 2004 | 161 | |
| 15 | 1994 | 158 | |
| 16 | 1994 | 148 | |
| 17 | 2011 | 147 | |
| 18 | 2005 | 141 | |
| 19 | 2008 | 138 | |
| 20 | 1986 | 135 |
About Thomas Cerny
Thomas Cerny is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Pharmacology and Genetics, having authored 216 papers that have together received 9.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), Lung Cancer Diagnosis and Treatment (19 papers), Pharmacogenetics and Drug Metabolism (14 papers), Lung Cancer Research Studies (13 papers), Cancer therapeutics and mechanisms (13 papers), Lung Cancer Treatments and Mutations (11 papers), Sarcoma Diagnosis and Treatment (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (2k citations), Pathology and Forensic Medicine (1.1k citations), Pulmonary and Respiratory Medicine (2k citations), Otorhinolaryngology (204 citations) and Genetics (295 citations). Thomas Cerny has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include Adrian Kupfer, N. Thatcher, Ulrich Güller, Daniel C. Betticher, Christine Aeschlimann, Florian Strasser, René Warschkow, Bruno Martin Schmied, Silke Gillessen and Rolf Arno Stahel. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.